Vivo Bio Tech Limited

BSE: 511509
Vivo Bio Tech Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials and compliance.
CIN L65993TG1987PLC007163 Incorporated 12 February 1987 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Listed - BSE: 511509 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹53.33 Cr
▲ 14.27% YoY
Computed EBITDA · FY 2026
₹21.89 Cr
▼ 13.53% YoY
Net profit · FY 2026
-₹1.71 Cr
▼ 123.47% YoY
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹22.19 Cr
Issued & subscribed
Open charges
₹165.24 Cr
Satisfied ₹90.8 Cr
Company age
39 yrs
Est. 1987
Employees · EPFO
5
Latest available

About Vivo Bio Tech Limited

Data last updated: 14 July 2026

Vivo Bio Tech Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 12 February 1987, the company has been in operation for over 39 years.

Registered with ROC Hyderabad under CIN L65993TG1987PLC007163. Listed on BSE: 511509.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹22.19 Cr. It is led by directors including Sri Kalyan Kompella and Sankaranarayanan Alangudi.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 03Rd Floor Ilyas Mohammed Khan Estate #8 – 2 – 672/5 & 6 Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034.

As per BSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹53.33 Cr, a growth of 14.27% compared to the previous year. The net worth stands at ₹93.16 Cr (up 19.58% YoY). Total assets are valued at ₹178.43 Cr (up 24.58% YoY).

The company has a workforce of approximately 5 employees as per the latest available data. Its group structure includes 4 subsidiaries.

The company is associated with 1 brand - Vivo Bio Tech. As per MCA filings, the company has open charges of ₹165.24 Cr and satisfied charges of ₹90.8 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vivobio.com.

Company Details of Vivo Bio Tech Limited
CIN L65993TG1987PLC007163
Registration Number 007163
Incorporation Date 12 February 1987
ROC Hyderabad
Listing Status Listed (BSE: 511509)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Sri Kalyan Kompella Whole-Time Director Sankaranarayanan Alangudi Whole-Time Director Kalyan Ram Mangipudi Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    vivobio.com
  • Social Media
  • Registered Address
    03Rd Floor Ilyas Mohammed Khan Estate #8 – 2 – 672/5 & 6 Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034
  • Industry
    Pharma, Pharma Contract R&D
Company report
Vivo Bio Tech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Vivo Bio Tech Limited report

Financials, compliance, directors, charges, ownership and filings for Vivo Bio Tech Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Vivo Bio Tech Limited

Vivo Bio Tech Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L65993TG1987PLC007163, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L65993TG1987PLC007163 Current
L65993AP1987PLC007163 Previous
U65993TG1987PLC007163 Previous

Associated Brands with Vivo Bio Tech Limited

Vivo Bio Tech Limited operates one associated brand: Vivo Bio Tech. These brands represent Vivo Bio Tech Limited's diversified market presence and brand portfolio.

Brand Description Website
Vivo Bio Tech
CRO providing drug development, discovery and biologic research services vivobio.com

Competitors & Alternatives of Vivo Bio Tech Limited

Brands and companies operating in the same space as Vivo Bio Tech Limited include GenOway, PsychoGenics, PharmaLegacy Laboratories and 6 more.

Competitor Description Location Founded
GenOway GenOway Provider of transgenic rodent models and customized cell lines for preclinical development Lyon, France, France 1999
PsychoGenics PsychoGenics Preclinical CRO services for CNS and orphan disorders are offered. Tarrytown, United States, United States 1999
PharmaLegacy Laboratories PharmaLegacy Laboratories Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas Shanghai, China, China 2008
TransCure bioServices TransCure bioServices Humanized mouse models are developed for preclinical immune drug studies. Archamps, France, France 2012
InVivo Biosystems InVivo Biosystems Animal models are supplied for in-vivo analytical services. United States 2019
Explora BioLabs Explora BioLabs Discovery pharmacology and vivarium services are provided to biotech clients. San Diego, United States, United States 2004
Noble Life Sciences Noble Life Sciences Preclinical contract research organization offering standard GLP and non-GLP services Woodbine, United States, United States 2010
ZeClinics ZeClinics Zebrafish models for toxicity studies are developed by ZeClinics CRO. Barcelona, Spain, Spain 2013
Zebrafish Lab Zebrafish Lab Zebrafish assays are utilized for preclinical and environmental evaluations. Noain, Spain, Spain 2015

Business Activity of Vivo Bio Tech Limited

Vivo Bio Tech Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including scientific research and development.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M5 Scientific research and development Locked
Premium access

Business activity turnover details for Vivo Bio Tech Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Vivo Bio Tech Limited

Vivo Bio Tech Limited is audited by P MURALI & CO., (ICAI peer reviewed, certificate valid till 2028-11-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
P MURALI & CO., (ICAI peer reviewed, certificate valid till 2028-11-30) FY 2026 Declaration of unmodified opinion

Board of Directors of Vivo Bio Tech Limited

Vivo Bio Tech Limited is currently managed by 6 directors, with 19 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sri Kalyan Kompella
Also directs: Pragnapur Developers Private Limited, Shri Shri Resorts Private Limited, Gajwel Developers Private Limited and 5 more
Whole-Time Director 03 Nov 2021 4 Years 9 Months Current
Sankaranarayanan Alangudi
Also directs: Vivobio Discovery Services Private Limited, Vivobio Labs Private Limited, Surlogic Life Consultancy Private Limited and 2 more
Whole-Time Director 27 May 2016 10 Years 2 Months Current
Kalyan Ram Mangipudi
Also directs: Vivobio Discovery Services Private Limited, Bharat Megawatts Gen Private Limited, Pragnapur Developers Private Limited and 5 more
Whole-Time Director 26 Nov 2009 16 Years 8 Months Current
Priya Rajender Goda
Also directs: Virinchi Limited
Director 11 Jun 2025 1 Years 2 Months Current
Satyanarayana Vedula
Also directs: Virinchi Limited, Tyohar Foods Private Limited, V23 Medical Solutions Private Limited and 4 more
Director 11 Jun 2025 1 Years 2 Months Current
Shyam Sunder Tipparaju
Also directs: Vivobio Discovery Services Private Limited, Vivobio Labs Private Limited, Surlogic Life Consultancy Private Limited and 5 more
Director 31 Aug 2023 2 Years 11 Months Current
View all directors

Financials of Vivo Bio Tech Limited FY 2026 filings available

Vivo Bio Tech Limited reported revenue of ₹53.33 Cr (up 14.27% YoY) for FY 2026.

Revenue · FY 2026
₹53.33 Cr ▲ 14.27%
Profit · FY 2026
-₹1.71 Cr ▼ 123.47%
Computed EBITDA · FY 2026
₹21.89 Cr ▼ 13.53%
Revenue₹ Cr · Consolidated0204060FY 2020: ₹55 Cr55.4FY 2020FY 2021: ₹52 Cr · -6.5% YoY51.8-6.5%FY 2021FY 2022: ₹51 Cr · -0.7% YoY51.4-0.7%FY 2022FY 2023: ₹52 Cr · +1.6% YoY52.2+1.6%FY 2023FY 2024: ₹45 Cr · -13% YoY45.5-13%FY 2024FY 2025: ₹47 Cr · +2.7% YoY46.7+2.7%FY 2025FY 2026: ₹53 Cr · +14.3% YoY53.3+14.3%FY 2026
Net Profit₹ Cr · Consolidated-2.502.557.5FY 2020: ₹4 Cr4.4FY 2020FY 2021: ₹6 Cr · +27.9% YoY5.7+27.9%FY 2021FY 2022: ₹2 Cr · -61.3% YoY2.2-61.3%FY 2022FY 2023: ₹3 Cr · +20.3% YoY2.6+20.3%FY 2023FY 2024: ₹3 Cr · -4.6% YoY2.5-4.6%FY 2024FY 2025: ₹7 Cr · +188.3% YoY7.3+188.3%FY 2025FY 2026: ₹2 Cr (loss) · -123.5% YoY-1.7FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year051015Q1'25: ₹10 Cr10.1Q1'25Q2'25: ₹12 Cr12Q2'25Q3'25: ₹12 Cr12.2Q3'25Q4'25: ₹12 Cr12.3Q4'25Q1'26: ₹13 Cr · +23.5% YoY12.5+23.5%Q1'26Q2'26: ₹13 Cr · +8.9% YoY13.1+8.9%Q2'26Q3'26: ₹14 Cr · +10.6% YoY13.5+10.6%Q3'26Q4'26: ₹14 Cr · +15.5% YoY14.2+15.5%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹53.33 Cr ₹46.67 Cr ₹45.45 Cr ₹52.23 Cr ₹51.39 Cr ₹51.78 Cr ₹55.35 Cr
Other Income ₹44.08 Lakh ₹4.8 Cr ₹3.88 Lakh ₹3.59 Lakh ₹9.83 Lakh ₹7.87 Lakh ₹5.32 Lakh
Total Income ₹53.78 Cr ₹51.48 Cr ₹45.49 Cr ₹52.27 Cr ₹51.49 Cr ₹51.85 Cr ₹55.41 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹8.49 Cr ₹4.81 Cr ₹4.65 Cr ₹4.93 Cr ₹7.97 Cr ₹9.91 Cr ₹10.9 Cr
Changes in Inventories -₹36.19 Lakh ₹98.35 Lakh -₹80.13 Lakh ₹1.84 Cr ₹3.47 Cr -₹2.7 Cr -₹2.34 Cr
Employee Benefit Expense ₹16.49 Cr ₹12.14 Cr ₹10.68 Cr ₹13.52 Cr ₹9.42 Cr ₹8.57 Cr ₹10 Cr
Finance Costs ₹5.85 Cr ₹7.5 Cr ₹7.78 Cr ₹7.65 Cr ₹3.99 Cr ₹3.53 Cr ₹3.1 Cr
Depreciation & Amortisation ₹10.63 Cr ₹9.02 Cr ₹9.29 Cr ₹9.27 Cr ₹7.45 Cr ₹5.59 Cr ₹5.17 Cr
Other Expenses ₹7.27 Cr ₹8.23 Cr ₹9.83 Cr ₹10.43 Cr ₹14.72 Cr ₹18.34 Cr ₹24.33 Cr
Total Expenses ₹48.36 Cr ₹42.68 Cr ₹41.43 Cr ₹47.65 Cr ₹47.02 Cr ₹43.23 Cr ₹51.15 Cr
Profit Before Exceptional Items & Tax ₹5.41 Cr ₹8.79 Cr ₹4.06 Cr ₹4.62 Cr ₹4.47 Cr ₹8.62 Cr ₹4.25 Cr
Exceptional Items -₹60.45 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹4.81 Cr ₹8.79 Cr ₹4.06 Cr ₹4.62 Cr ₹4.47 Cr ₹8.62 Cr ₹4.25 Cr
Total Tax Expense ₹6.52 Cr ₹1.51 Cr ₹1.53 Cr ₹1.97 Cr ₹2.27 Cr ₹2.94 Cr -₹18.82 Lakh
Net Profit -₹1.71 Cr ₹7.28 Cr ₹2.53 Cr ₹2.65 Cr ₹2.2 Cr ₹5.68 Cr ₹4.44 Cr
  attributable to Owners - - ₹2.53 Cr ₹2.65 Cr ₹0 ₹5.68 Cr ₹4.44 Cr
  attributable to NCI - - ₹0 ₹0 ₹0 ₹0 ₹0
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹4.44 Cr
Total Comprehensive Income -₹1.71 Cr ₹7.28 Cr ₹2.53 Cr ₹2.65 Cr ₹2.2 Cr ₹5.68 Cr ₹8.88 Cr
EBITDA (computed) ₹21.89 Cr ₹25.31 Cr ₹21.13 Cr ₹21.54 Cr ₹15.91 Cr ₹17.74 Cr ₹12.52 Cr
Basic EPS ₹-0.82 ₹4.76 ₹1.70 ₹1.78 ₹1.56 ₹4.23 ₹3.45
Diluted EPS ₹-0.82 ₹4.76 ₹1.51 ₹1.78 ₹1.56 ₹4.20 ₹3.45
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Total Assets ₹178.43 Cr ₹143.23 Cr ₹137.13 Cr ₹123.03 Cr ₹122.49 Cr ₹79.52 Cr ₹62.14 Cr
Non-current Assets ₹150.02 Cr ₹101.29 Cr ₹89.9 Cr ₹91.24 Cr ₹96.45 Cr ₹52.44 Cr ₹35.22 Cr
Current Assets ₹28.42 Cr ₹41.94 Cr ₹47.23 Cr ₹31.79 Cr ₹26.03 Cr ₹27.09 Cr ₹26.92 Cr
Property, Plant & Equipment ₹71.8 Cr ₹64.38 Cr ₹72.25 Cr ₹78.07 Cr ₹81.55 Cr ₹40.71 Cr ₹28.61 Cr
Inventories ₹8.15 Cr ₹7.79 Cr ₹8.77 Cr ₹7.97 Cr ₹9.81 Cr ₹13.28 Cr ₹10.58 Cr
Trade Receivables ₹11.75 Cr ₹11.25 Cr ₹11.8 Cr ₹12.38 Cr ₹12.02 Cr ₹7.29 Cr ₹10.48 Cr
Cash & Equivalents ₹1.44 Cr ₹1.28 Cr ₹1.39 Cr ₹1.37 Cr ₹1.71 Cr ₹1.17 Cr ₹1.03 Cr
Equity (Net Worth) ₹93.16 Cr ₹77.9 Cr ₹54.4 Cr ₹51.87 Cr ₹45.95 Cr ₹42.53 Cr ₹33.02 Cr
Equity Share Capital ₹22.19 Cr ₹17.16 Cr ₹14.9 Cr ₹14.9 Cr ₹14.26 Cr ₹13.42 Cr ₹12.89 Cr
Borrowings (Non-current) ₹46.61 Cr ₹34.94 Cr ₹41.79 Cr ₹43.09 Cr ₹50.08 Cr ₹14.65 Cr ₹9.69 Cr
Borrowings (Current) ₹20.77 Cr ₹19.09 Cr ₹31.28 Cr ₹19.3 Cr ₹17.36 Cr ₹16.31 Cr ₹14.67 Cr
Total Debt (computed) ₹67.38 Cr ₹54.03 Cr ₹73.06 Cr ₹62.4 Cr ₹67.44 Cr ₹30.96 Cr ₹24.36 Cr
Current Liabilities ₹30.23 Cr ₹27.84 Cr ₹37.91 Cr ₹24.97 Cr ₹24.36 Cr ₹21.84 Cr ₹20.56 Cr
Total Liabilities ₹85.27 Cr ₹65.33 Cr ₹82.73 Cr ₹71.16 Cr ₹76.54 Cr ₹37 Cr ₹29.12 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹34.93 Cr ₹11.83 Cr ₹15.52 Cr ₹7.37 Cr ₹15.01 Cr
Investing Cash Flow -₹59.35 Cr -₹15.84 Cr -₹7.95 Cr -₹4 Cr -₹51.11 Cr
Financing Cash Flow ₹24.57 Cr ₹3.9 Cr -₹7.56 Cr -₹3.71 Cr ₹36.65 Cr
Capital Expenditure ₹37.44 Cr ₹22.5 Lakh ₹7.95 Cr ₹4 Cr ₹51.11 Cr
Free Cash Flow (computed) -₹2.51 Cr ₹11.6 Cr ₹7.57 Cr ₹3.37 Cr -₹36.1 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹15.48 Lakh -₹10.9 Lakh ₹1.48 Lakh -₹33.88 Lakh ₹55.23 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹14.2 Cr ₹13.51 Cr ₹13.11 Cr ₹12.51 Cr ₹12.29 Cr ₹12.21 Cr ₹12.04 Cr ₹10.13 Cr
Other Income ₹3.04 Lakh ₹13.86 Lakh ₹13.39 Lakh ₹13.78 Lakh ₹15.31 Lakh ₹85,000 ₹4.63 Cr ₹1.23 Lakh
Total Income ₹14.23 Cr ₹13.65 Cr ₹13.24 Cr ₹12.65 Cr ₹12.44 Cr ₹12.22 Cr ₹16.67 Cr ₹10.15 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹2.77 Cr ₹2.98 Cr ₹1.11 Cr ₹1.63 Cr ₹1.56 Cr ₹83.35 Lakh ₹90.57 Lakh ₹1.51 Cr
Changes in Inventories -₹40.26 Lakh -₹81.83 Lakh ₹98.76 Lakh -₹12.86 Lakh -₹79.16 Lakh ₹1.03 Cr ₹57.06 Lakh ₹17.21 Lakh
Employee Benefit Expense ₹4.88 Cr ₹4.33 Cr ₹4.08 Cr ₹3.2 Cr ₹3.14 Cr ₹3.22 Cr ₹3.44 Cr ₹2.34 Cr
Finance Costs ₹1.48 Cr ₹1.4 Cr ₹1.47 Cr ₹1.5 Cr ₹1.68 Cr ₹1.84 Cr ₹2.06 Cr ₹1.92 Cr
Depreciation & Amortisation ₹2.75 Cr ₹2.66 Cr ₹2.57 Cr ₹2.64 Cr ₹2.25 Cr ₹2.25 Cr ₹2.29 Cr ₹2.23 Cr
Other Expenses ₹1.9 Cr ₹1.53 Cr ₹1.52 Cr ₹2.31 Cr ₹3.36 Cr ₹1.59 Cr ₹1.52 Cr ₹1.75 Cr
Total Expenses ₹13.38 Cr ₹12.08 Cr ₹11.73 Cr ₹11.17 Cr ₹11.2 Cr ₹10.76 Cr ₹10.8 Cr ₹9.92 Cr
Profit Before Exceptional Items & Tax ₹85.55 Lakh ₹1.57 Cr ₹1.51 Cr ₹1.48 Cr ₹1.24 Cr ₹1.46 Cr ₹5.87 Cr ₹22.24 Lakh
Exceptional Items -₹60.45 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹25.1 Lakh ₹1.57 Cr ₹1.51 Cr ₹1.48 Cr ₹1.24 Cr ₹1.46 Cr ₹5.87 Cr ₹22.24 Lakh
Total Tax Expense ₹5.41 Cr ₹32.16 Lakh ₹64.05 Lakh ₹14.28 Lakh ₹17.87 Lakh ₹64.19 Lakh ₹63.35 Lakh ₹5.62 Lakh
Net Profit -₹5.16 Cr ₹1.25 Cr ₹86.86 Lakh ₹1.34 Cr ₹1.06 Cr ₹82 Lakh ₹5.23 Cr ₹16.62 Lakh
  attributable to Owners - - - ₹0 - - ₹0 ₹16.62 Lakh
  attributable to NCI - - - ₹0 - - ₹0 ₹0
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹5.16 Cr ₹1.25 Cr ₹86.86 Lakh ₹1.34 Cr ₹1.06 Cr ₹82 Lakh ₹5.23 Cr ₹16.62 Lakh
EBITDA (computed) ₹5.08 Cr ₹5.63 Cr ₹5.55 Cr ₹5.63 Cr ₹5.17 Cr ₹5.55 Cr ₹10.22 Cr ₹4.38 Cr
Basic EPS ₹-2.52 ₹0.56 ₹0.45 ₹0.74 ₹0.69 ₹0.55 ₹3.51 ₹0.11
Diluted EPS ₹-2.52 ₹0.56 ₹0.45 ₹0.74 ₹0.69 ₹0.55 ₹3.51 ₹0.11
Latest 8 quarters shown.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹52.57 Cr ₹46.67 Cr ₹44.88 Cr ₹51.62 Cr ₹51.39 Cr ₹51.78 Cr ₹55.35 Cr
Other Income ₹44.08 Lakh ₹4.8 Cr ₹3.88 Lakh ₹3.59 Lakh ₹9.21 Lakh ₹7.87 Lakh ₹5.32 Lakh
Total Income ₹53.01 Cr ₹51.48 Cr ₹44.92 Cr ₹51.66 Cr ₹51.48 Cr ₹51.85 Cr ₹55.41 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹8.49 Cr ₹4.81 Cr ₹4.65 Cr ₹4.93 Cr ₹7.97 Cr ₹9.91 Cr ₹10.9 Cr
Changes in Inventories -₹36.19 Lakh ₹98.35 Lakh -₹80.13 Lakh ₹1.84 Cr ₹3.47 Cr -₹2.7 Cr -₹2.34 Cr
Employee Benefit Expense ₹15.95 Cr ₹11.86 Cr ₹10.13 Cr ₹13.15 Cr ₹9.42 Cr ₹8.57 Cr ₹10 Cr
Finance Costs ₹5.85 Cr ₹7.5 Cr ₹7.78 Cr ₹7.65 Cr ₹3.99 Cr ₹3.53 Cr ₹3.1 Cr
Depreciation & Amortisation ₹10.63 Cr ₹9.02 Cr ₹9.29 Cr ₹9.27 Cr ₹7.44 Cr ₹5.59 Cr ₹5.17 Cr
Other Expenses ₹7.27 Cr ₹8.22 Cr ₹9.81 Cr ₹10.22 Cr ₹14.72 Cr ₹18.33 Cr ₹24.32 Cr
Total Expenses ₹47.82 Cr ₹42.4 Cr ₹40.86 Cr ₹47.05 Cr ₹47.01 Cr ₹43.23 Cr ₹51.15 Cr
Profit Before Exceptional Items & Tax ₹5.19 Cr ₹9.08 Cr ₹4.05 Cr ₹4.61 Cr ₹4.47 Cr ₹8.62 Cr ₹4.26 Cr
Exceptional Items -₹60.45 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹4.58 Cr ₹9.08 Cr ₹4.05 Cr ₹4.61 Cr ₹4.47 Cr ₹8.62 Cr ₹4.26 Cr
Total Tax Expense ₹6.52 Cr ₹1.51 Cr ₹1.53 Cr ₹1.97 Cr ₹2.27 Cr ₹2.94 Cr -₹18.82 Lakh
Net Profit -₹1.94 Cr ₹7.57 Cr ₹2.52 Cr ₹2.63 Cr ₹2.2 Cr ₹5.68 Cr ₹4.44 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹1.94 Cr ₹7.57 Cr ₹2.52 Cr ₹2.63 Cr ₹2.2 Cr ₹5.68 Cr ₹4.44 Cr
EBITDA (computed) ₹21.66 Cr ₹25.6 Cr ₹21.12 Cr ₹21.52 Cr ₹15.91 Cr ₹17.74 Cr ₹12.53 Cr
Basic EPS ₹-0.93 ₹4.95 ₹1.69 ₹1.77 ₹1.56 ₹4.24 ₹3.45
Diluted EPS ₹-0.93 ₹4.95 ₹1.51 ₹1.77 ₹1.56 ₹4.20 ₹3.45
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Total Assets ₹174.86 Cr ₹141.29 Cr ₹134.8 Cr ₹120.81 Cr ₹120.3 Cr ₹77.31 Cr ₹59.87 Cr
Non-current Assets ₹146.7 Cr ₹97.97 Cr ₹86.58 Cr ₹87.92 Cr ₹93.12 Cr ₹49.1 Cr ₹31.88 Cr
Current Assets ₹28.17 Cr ₹43.31 Cr ₹48.22 Cr ₹32.88 Cr ₹27.18 Cr ₹28.21 Cr ₹27.99 Cr
Property, Plant & Equipment ₹68.44 Cr ₹61.02 Cr ₹68.89 Cr ₹74.71 Cr ₹78.19 Cr ₹37.35 Cr ₹25.25 Cr
Inventories ₹8.15 Cr ₹7.79 Cr ₹8.77 Cr ₹7.97 Cr ₹9.81 Cr ₹13.28 Cr ₹10.58 Cr
Trade Receivables ₹11.75 Cr ₹11.21 Cr ₹11.37 Cr ₹12.38 Cr ₹12.02 Cr ₹7.29 Cr ₹10.48 Cr
Cash & Equivalents ₹1.3 Cr ₹1.21 Cr ₹1.32 Cr ₹99.37 Lakh ₹1.47 Cr ₹1.1 Cr ₹99.06 Lakh
Equity (Net Worth) ₹93.22 Cr ₹78.19 Cr ₹54.4 Cr ₹51.87 Cr ₹47.14 Cr ₹42.54 Cr ₹33.04 Cr
Equity Share Capital ₹22.19 Cr ₹17.16 Cr ₹14.9 Cr ₹14.9 Cr ₹14.26 Cr ₹13.42 Cr ₹12.89 Cr
Borrowings (Non-current) ₹43.15 Cr ₹32.71 Cr ₹39.56 Cr ₹40.87 Cr ₹47.88 Cr ₹12.42 Cr ₹7.41 Cr
Borrowings (Current) ₹20.77 Cr ₹19.09 Cr ₹31.28 Cr ₹19.3 Cr ₹17.36 Cr ₹16.31 Cr ₹14.67 Cr
Total Debt (computed) ₹63.92 Cr ₹51.8 Cr ₹70.84 Cr ₹60.17 Cr ₹65.24 Cr ₹28.73 Cr ₹22.09 Cr
Current Liabilities ₹30.07 Cr ₹27.84 Cr ₹37.81 Cr ₹24.97 Cr ₹23.18 Cr ₹21.83 Cr ₹20.56 Cr
Total Liabilities ₹81.65 Cr ₹63.1 Cr ₹80.4 Cr ₹68.93 Cr ₹73.15 Cr ₹34.77 Cr ₹26.84 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹36.11 Cr ₹11.83 Cr ₹15.83 Cr ₹8.44 Cr ₹13.62 Cr
Investing Cash Flow -₹59.35 Cr -₹15.84 Cr -₹7.95 Cr -₹4 Cr -₹51.11 Cr
Financing Cash Flow ₹23.34 Cr ₹3.9 Cr -₹7.56 Cr -₹4.92 Cr ₹37.85 Cr
Capital Expenditure ₹37.44 Cr ₹22.5 Lakh ₹7.95 Cr ₹4 Cr ₹51.11 Cr
Free Cash Flow (computed) -₹1.33 Cr ₹11.61 Cr ₹7.88 Cr ₹4.44 Cr -₹37.49 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹9.4 Lakh -₹10.71 Lakh ₹32.23 Lakh -₹47.26 Lakh ₹36.39 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹13.77 Cr ₹13.37 Cr ₹13.02 Cr ₹12.42 Cr ₹12.29 Cr ₹12.21 Cr ₹12.04 Cr ₹10.13 Cr
Other Income ₹3.04 Lakh ₹13.86 Lakh ₹13.39 Lakh ₹13.78 Lakh ₹15.31 Lakh ₹85,000 ₹4.63 Cr ₹1.23 Lakh
Total Income ₹13.8 Cr ₹13.5 Cr ₹13.15 Cr ₹12.56 Cr ₹12.44 Cr ₹12.22 Cr ₹16.67 Cr ₹10.15 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹2.77 Cr ₹2.98 Cr ₹1.11 Cr ₹1.63 Cr ₹1.56 Cr ₹83.35 Lakh ₹90.57 Lakh ₹1.51 Cr
Changes in Inventories -₹40.26 Lakh -₹81.83 Lakh ₹98.76 Lakh -₹12.86 Lakh -₹79.16 Lakh ₹1.03 Cr ₹57.06 Lakh ₹17.21 Lakh
Employee Benefit Expense ₹4.72 Cr ₹4.17 Cr ₹3.99 Cr ₹3.07 Cr ₹3.02 Cr ₹3.14 Cr ₹3.36 Cr ₹2.33 Cr
Finance Costs ₹1.48 Cr ₹1.4 Cr ₹1.47 Cr ₹1.5 Cr ₹1.68 Cr ₹1.84 Cr ₹2.06 Cr ₹1.92 Cr
Depreciation & Amortisation ₹2.75 Cr ₹2.66 Cr ₹2.57 Cr ₹2.64 Cr ₹2.25 Cr ₹2.25 Cr ₹2.29 Cr ₹2.23 Cr
Other Expenses ₹1.9 Cr ₹1.53 Cr ₹1.52 Cr ₹2.31 Cr ₹3.36 Cr ₹1.59 Cr ₹1.52 Cr ₹1.75 Cr
Total Expenses ₹13.22 Cr ₹11.92 Cr ₹11.64 Cr ₹11.04 Cr ₹11.08 Cr ₹10.68 Cr ₹10.72 Cr ₹9.91 Cr
Profit Before Exceptional Items & Tax ₹58.13 Lakh ₹1.58 Cr ₹1.51 Cr ₹1.52 Cr ₹1.36 Cr ₹1.54 Cr ₹5.95 Cr ₹23.4 Lakh
Exceptional Items -₹60.45 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax -₹2.32 Lakh ₹1.58 Cr ₹1.51 Cr ₹1.52 Cr ₹1.36 Cr ₹1.54 Cr ₹5.95 Cr ₹23.4 Lakh
Total Tax Expense ₹5.41 Cr ₹32.16 Lakh ₹64.05 Lakh ₹14.28 Lakh ₹17.87 Lakh ₹64.19 Lakh ₹63.35 Lakh ₹5.62 Lakh
Net Profit -₹5.44 Cr ₹1.26 Cr ₹86.92 Lakh ₹1.37 Cr ₹1.19 Cr ₹89.43 Lakh ₹5.31 Cr ₹17.78 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹5.44 Cr ₹1.26 Cr ₹86.92 Lakh ₹1.37 Cr ₹1.19 Cr ₹89.43 Lakh ₹5.31 Cr ₹17.78 Lakh
EBITDA (computed) ₹4.81 Cr ₹5.64 Cr ₹5.55 Cr ₹5.66 Cr ₹5.29 Cr ₹5.62 Cr ₹10.3 Cr ₹4.39 Cr
Basic EPS ₹-2.65 ₹0.57 ₹0.45 ₹0.76 ₹0.78 ₹0.60 ₹3.56 ₹0.12
Diluted EPS ₹-2.65 ₹0.57 ₹0.45 ₹0.76 ₹0.78 ₹0.60 ₹3.56 ₹0.12
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Vivo Bio Tech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Vivo Bio Tech Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 35.43%, retail and other public shareholders hold 64.57% of Vivo Bio Tech Limited. The company had 21,427 shareholders on record.

Promoters: 35.43%Retail & Others: 64.57%
Mar 2026
QUARTER
35.43% Promoters
64.57% Retail & Others
Promoter holding - history
Now 35.43% · Mar 2026High 42.08% · Jun 2023Low 35.16% · Sep 2025
34%36.5%39%41.5%44%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 42.08%Sep 2023: 42.08%Dec 2023: 42.08%Mar 2024: 42.08%Jun 2024: 42.08%Sep 2024: 42.08%Dec 2024: 38.88%Mar 2025: 40.85%Jun 2025: 39.06%Sep 2025: 35.16%Dec 2025: 35.16%Mar 2026: 35.43%42.08%35.16%35.43%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters35.43%35.16%35.16%39.06%40.85%38.88%
Public64.57%64.84%64.84%60.94%59.15%61.12%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters35.43%40.85%42.08%
Public64.57%59.15%57.92%
Promoter change (YoY, %pts)-5.42-1.23-

Group Structure of Vivo Bio Tech Limited

Vivo Bio Tech Limited has 4 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Vivo Bio Tech Limited's business expansion strategy and organizational complexity.

4
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Vivobio Discovery Services Private Limited U24232TG2009PTC065604 -
Vivobio Labs Private Limited U73100TG2009PTC065603 -
Surlogic Life Consultancy Private Limited U74999TG2010PTC068943 -
Vivobio Consulting Services Private Limited U74999TG2018PTC125356 -

Showing major subsidiaries. Total: 4.

Charges & Borrowings of Vivo Bio Tech Limited

Open charges
₹165.24 Cr
Satisfied charges
₹90.8 Cr
Breakdown by lending institutions
Canara Bank₹133.44 Cr
Others₹19.55 Cr
The South Indian Bank Limited₹6.45 Cr
Department of Biotechnology₹5.70 Cr
Bank of Baroda₹0.10 Cr
Latest charge details
DateLenderAmountStatus
02 Jul 2026 The South Indian Bank Limited ₹77.9 Lakh Open
23 Jun 2026 The South Indian Bank Limited ₹35.25 Lakh Open
26 Nov 2025 Others ₹7.57 Cr Open
25 Sep 2025 The South Indian Bank Limited ₹52 Lakh Open
25 Sep 2025 Others ₹3.65 Cr Open

Total charge records: 30 View all charges

Employees and EPFO Compliance at Vivo Bio Tech Limited

Vivo Bio Tech Limited has a workforce of 5 employees as of Apr 06, 2024.

Employee count
5
Active EPFO establishments
2
Employee growth
-94.9%
Premium access

Employee and EPFO history for Vivo Bio Tech Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Vivo Bio Tech Limited

Premium access

GST registrations and filing compliance for Vivo Bio Tech Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Vivo Bio Tech Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Vivo Bio Tech Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Vivo Bio Tech Limited

Premium access

MSME payment history for Vivo Bio Tech Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Vivo Bio Tech Limited

Premium access

Corporate group structure for Vivo Bio Tech Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Vivo Bio Tech Limited

Premium access

MCA filings and documents for Vivo Bio Tech Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Vivo Bio Tech Limited

Charges
02 Jul 2026
A charge with The South Indian Bank Limited amounted to Rs. 0.78 Cr with Charge ID 101321205 was registered on 02 Jul 2026.
Charges
23 Jun 2026
A charge with The South Indian Bank Limited amounted to Rs. 0.35 Cr with Charge ID 101321210 was registered on 23 Jun 2026.
Charges
15 Jun 2026
A charge registered on 17 Oct 2023 via Charge ID 100854356 with Others was fully satisfied on 15 Jun 2026.
Charges
15 Jun 2026
A charge registered on 17 Oct 2023 via Charge ID 100854358 with Others was fully satisfied on 15 Jun 2026.
Charges
19 Feb 2026
A charge with Canara Bank of Rs. 64.39 Cr registered on 14 Oct 2016 with Charge ID 100075099 was modified on 19 Feb 2026.
Charges
26 Nov 2025
A charge with Others amounted to Rs. 7.57 Cr with Charge ID 101209687 was registered on 26 Nov 2025.

Recent News on Vivo Bio Tech Limited

Frequently Asked Questions about Vivo Bio Tech Limited

Vivo Bio Tech Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 12 February 1987 (39+ years old) and is registered under CIN L65993TG1987PLC007163. Listed on BSE: 511509. The company has 5 employees.

Vivo Bio Tech Limited reported revenue of ₹53.33 Cr for FY 2026 (up 14.27% YoY) based on consolidated BSE filings.

The current directors of Vivo Bio Tech Limited are:

The primary industry of Vivo Bio Tech Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.

Yes. Vivo Bio Tech Limited is listed on BSE with code 511509.

Vivo Bio Tech Limited can be reached at the registered office: 03Rd Floor Ilyas Mohammed Khan Estate #8 – 2 – 6725 & 6 Road No.1 Banjara Hills, Hyderabad, Telangana, India – 500034, or through the website vivobio.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available